MedPath

Effects of High Protein Diet on Muscle Mass, Strength, and Physical Performance in Postmenopausal Women

Not Applicable
Completed
Conditions
Muscle Loss
Physical Disability
Interventions
Other: High Protein Diet
Other: Control Diet
Registration Number
NCT03652584
Lead Sponsor
Hospital de Clinicas de Porto Alegre
Brief Summary

Despite the importance of preventing muscle mass loss during senescence, only a few studies have investigated the relationship between diet and muscle mass in postmenopausal women. Therefore, the aim of this study is to investigate whether controlled protein consumption at the current Recommended Daily Allowance (RDA = 0.8 g/kg body weight) or twice the RDA (1.6 g/kg body weight) affects skeletal muscle mass, strength, and physical performance in postmenopausal women. In this parallel-group trial, participants were randomized for 6 months to low glycemic index diets with controlled protein consumption at the current RDA or twice the RDA, aimed to balance energy needs.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
28
Inclusion Criteria
  • Postmenopausal women
  • Without mobility aids, able to perform activities of daily living independently
Exclusion Criteria
  • Use of hormone therapy in the past 3 months
  • Insulin therapy
  • Previous diagnosis of heart disease
  • Untreated thyroid diseases
  • Conditions affecting neuromuscular function

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
High Protein DietHigh Protein DietLow glycemic index dietary plan with 1.6 g/kg/day of protein for 6 months
Control DietControl DietLow glycemic index dietary plan with 0.8 g/kg/day of protein for 6 months
Primary Outcome Measures
NameTimeMethod
Change in whole-body and appendicular lean mass6 months

measured by dual-energy X-ray absorptiometry

Secondary Outcome Measures
NameTimeMethod
Change in diastolic blood pressure6 months

in mmHg

Change in fat mass6 months

measured by dual-energy X-ray absorptiometry

Change in total cholesterol, high-density lipoprotein cholesterol, and triglycerides6 months

determined by colorimetric-enzymatic methods

Change in glucose6 months

determined by the hexokinase method

Change in systolic blood pressure6 months

in mmHg

Change in isometric hand grip strength6 months

measured by dynamometry

Change in usual gait speed6 months

in a 4-m course

Change in high-sensitivity C-reactive protein6 months

measured by nephelometric method

Change in insulin6 months

measured by chemiluminescence immunoassays

Change in resting metabolic rate6 months

measured by indirect calorimetry

© Copyright 2025. All Rights Reserved by MedPath